Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Lilly releases Zepbound (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Image INDIANAPOLIS- Eli Lilly and Company (NYSE: LLY) today announced Zepbound (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly expanding the supply of Zepbound in response to high demand
Vitamin D, magnesium, and iron deficiencies are frequently documented in patients on long-term GLP-1 therapy
Protein is essential for tissue repair
The Most Effective GLP-1
US$ 28.85
US$ 23.49
US$ 27.44
US$ 25.74
US$ 20.51
US$ 24.56
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
US$ 22.15
US$ 25.24
